+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Progesterone"

From
HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Dysmenorrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Dysmenorrhea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 180 Pages
  • Global
From
Global Hormone Replacement Therapy Market 2024-2028 - Product Thumbnail Image

Global Hormone Replacement Therapy Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
Uterine fibroids - Pipeline Insight, 2024 - Product Thumbnail Image

Uterine fibroids - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Selective estrogen receptor degraders - Pipeline Insight, 2024 - Product Thumbnail Image

Selective estrogen receptor degraders - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Endometriosis Treatment Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Endometriosis Treatment Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
From
From
Loading Indicator

Progesterone is a hormone that plays an important role in women's health. It is produced by the ovaries and is essential for the regulation of the menstrual cycle, fertility, and pregnancy. Progesterone is also used to treat a variety of conditions, including abnormal uterine bleeding, endometriosis, and premenstrual syndrome. It is available in a variety of forms, including oral tablets, topical creams, and injections. The progesterone market is an important part of the women's health industry. It is driven by the increasing prevalence of conditions such as endometriosis and premenstrual syndrome, as well as the growing demand for hormone replacement therapy. The market is also influenced by the availability of new products and technologies, such as transdermal patches and vaginal rings. Some companies in the progesterone market include Pfizer, Merck, AbbVie, and Novo Nordisk. Show Less Read more